Skip to Content

Nanoworms Target Tumors

A new shape for nanoparticles helps deliver imaging agents.
May 14, 2008

Early-stage tumors are often too small to see with magnetic resonance imaging (MRI). Now, a team of researchers has developed magnetic “nanoworm” particles that can circulate for a day in the bloodstream and home in on tumors, helping to enhance an MRI image. The nanoworms could make it easier to image small tumors, allowing cancer to be detected and treated earlier.

Magnetic worms: Pictured are two micrographs of iron oxide nanoparticles that are strung together in a way that helps them slip past the body’s defenses. The top scale bar is 30 nanometers. The inset scale bar is 100 nanometers.

The research is part of a broader effort to treat cancer more effectively by delivering drugs and imaging agents directly to diseased cells using nanoparticles. But the challenge has been to create delivery vehicles that will circulate in the body long enough to find their way to a tumor in order to do their job. “You’re always fighting a battle with the body’s own rejection systems–the natural systems that try to get rid of any foreign body, such as a nanoparticle,” says Michael Sailor, a professor of chemistry and biochemistry at the University of California, San Diego.

One option is to chemically treat the nanoparticles so that they’re not recognized by the body’s immune system. But increasingly, researchers are also tailoring the nanoparticles’ shape to help them slip by defenses. The nanoworms created by Sailor and his colleagues consist of spherical iron oxide nanoparticles linked together so that they resemble the segments of an earthworm. The nanoworms are about 30 nanometers in length and are coated with a sugar called dextran that helps them evade the body’s rejection system. The shape also helps. Previous studies have shown that particles with an elongated shape are not eaten up by phagocytes, immune cells responsible for clearing such particles from the body, as readily as spherical ones are.

The new study “fits into the emerging evidence in nanomedicine that shape is very important,” says Mauro Ferrari, director of the Center for NanoMedicine and chair of the department of biomedical engineering at the University of Texas Health Sciences Center, in Houston. Controlling size and shape is a powerful way of directing drug carriers to their intended targets, Ferrari says.

Drugs could be attached to the nanoworms, but their impact will be mostly in their applications to imaging, Sailor says. Sailor, collaborating with Sangeeta Bhatia at MIT and Erkki Ruoslahti at the University of California, Santa Barbara, reported their findings in the journal Advanced Materials.

The synthesis of the nanoworms was somewhat unexpected, Sailor says. By using dextran molecules of slightly different weight, the researchers found that the particles spontaneously aggregated into strings of about eight to ten nanoparticles. Then Ji-Ho Park, a materials-science and engineering graduate student, tested their magnetic properties. Compared with individual iron oxide nanoparticles, the nanoworms produced a massively enhanced MRI signal. “Ultimately, this should lead us to image smaller tumors, so that would be at an earlier stage of development in the body,” Sailor says.

When injected into mice, the nanoworms accumulated in tumors, which was not surprising. “When [tumors] recruit blood vessels to feed themselves, the blood vessels tend to be very leaky,” Sailor says, so any kind of nanoparticle would have a tendency to collect there. But the nanoworms also stuck around much longer than individual iron oxide nanoparticles, which the body can eliminate in minutes. “If you make [a nanoparticle] bigger, then the body should have a better chance of finding it and eliminating it,” Sailor says. “So one of the surprises of the study was that these things would circulate for quite a long time. They had up to a 24-hour half-life.”

The researchers also took the nanoworms and attached a peptide called F3, developed by Ruoslahti and his colleagues, that targets the surface of cancer cells. In vitro, the modified nanoworms attached to cancer cells more effectively than individual nanoparticles did. Linking several nanoparticles together creates a cooperative effect, Sailor says. Once one F3 molecule contacts a cell surface, there are others nearby to do the same.

Sailor and his group are now looking at methods to amplify the effect of the nanoworms, finding means for them to recruit other particles to a tumor site in a way that blood might clot.

Keep Reading

Most Popular

still from Embodied Intelligence video
still from Embodied Intelligence video

These weird virtual creatures evolve their bodies to solve problems

They show how intelligence and body plans are closely linked—and could unlock AI for robots.

pig kidney transplant surgery
pig kidney transplant surgery

Surgeons have successfully tested a pig’s kidney in a human patient

The test, in a brain-dead patient, was very short but represents a milestone in the long quest to use animal organs in human transplants.

panpsychism concept
panpsychism concept

Is everything in the world a little bit conscious?

The idea that consciousness is widespread is attractive to many for intellectual and, perhaps, also emotional
reasons. But can it be tested? Surprisingly, perhaps it can.

We reviewed three at-home covid tests. The results were mixed.

Over-the-counter coronavirus tests are finally available in the US. Some are more accurate and easier to use than others.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.